These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 24709005)
21. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
22. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210 [TBL] [Abstract][Full Text] [Related]
23. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. de Bortoli N; Martinucci I; Savarino EV; Frazzoni M; Tutuian R; Tolone S; Piaggi P; Furnari M; Russo S; Bertani L; Macchia L; Savarino V; Marchi S Dig Liver Dis; 2015 Dec; 47(12):1027-32. PubMed ID: 26362613 [TBL] [Abstract][Full Text] [Related]
24. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866 [TBL] [Abstract][Full Text] [Related]
26. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. Sharma P; Johnson DA; Monyak JT; Illueca M Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754 [TBL] [Abstract][Full Text] [Related]
27. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring. Frazzoni M; Penagini R; Frazzoni L; de Bortoli N; Mauro A; Tolone S; Bertani H; Marsico M; Marocchi M; Marchi S; Conigliaro R; Savarino E Am J Gastroenterol; 2019 Oct; 114(10):1606-1613. PubMed ID: 31449157 [TBL] [Abstract][Full Text] [Related]
28. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease. Lee ES; Kim N; Lee SH; Park YS; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS Aliment Pharmacol Ther; 2009 Jul; 30(2):154-64. PubMed ID: 19392871 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M Digestion; 2020; 101(2):174-183. PubMed ID: 30897577 [TBL] [Abstract][Full Text] [Related]